Sanofi
SNY
$50.05
-$0.53-1.05%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.04B | 7.82B | -- | 7.28B | |
| Total Receivables | 9.64B | 11.00B | -- | 9.43B | |
| Inventory | 11.30B | 9.76B | -- | 11.37B | |
| Prepaid Expenses | -- | 926.60M | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 4.50B | 14.57B | -- | 4.15B | |
| Total Current Assets | 43.47B | 44.09B | -- | 32.23B | |
|
|
|||||
| Total Current Assets | 43.47B | 44.09B | -- | 32.23B | |
| Net Property, Plant & Equipment | 12.93B | 12.01B | -- | 12.73B | |
| Long-term Investments | 47.31B | 44.92B | -- | 53.66B | |
| Goodwill | 47.31B | 44.92B | -- | 53.66B | |
| Total Other Intangibles | 14.54B | 14.76B | -- | 19.42B | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 20.29B | 18.33B | -- | 18.16B | |
| Total Assets | 146.75B | 137.49B | -- | 139.03B | |
|
|
|||||
| Total Accounts Payable | 8.31B | 7.82B | -- | 7.96B | |
| Total Accrued Expenses | -- | 2.45B | -- | -- | |
| Short-term Debt | 163.24M | 207.06M | -- | 7.68B | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 8.72B | 4.43B | -- | 2.51B | |
| Total Finance Division Other Current Liabilities | 16.94B | 15.29B | -- | 14.01B | |
| Total Other Current Liabilities | 16.94B | 15.29B | -- | 14.01B | |
| Total Current Liabilities | 34.13B | 30.19B | -- | 32.17B | |
|
|
|||||
| Total Current Liabilities | 34.13B | 30.19B | -- | 32.17B | |
| Long-Term Debt | 15.50B | 12.21B | -- | 13.40B | |
| Short-term Debt | 163.24M | 207.06M | -- | 7.68B | |
| Capital Leases | 1.79B | 1.70B | -- | 1.86B | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 12.80B | 12.78B | -- | 13.39B | |
| Total Liabilities | 64.22B | 56.88B | -- | 60.81B | |
|
|
|||||
| Common Stock & APIC | 2.90B | 2.62B | -- | 3.05B | |
| Retained Earnings | -- | -- | -- | -- | |
| Treasury Stock & Other | 79.32B | 77.63B | -- | 74.83B | |
| Total Common Equity | 82.22B | 80.24B | -- | 77.88B | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 82.22B | 80.24B | -- | 77.88B | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | 318.26M | 362.36M | -- | 328.94M | |
| Total Equity | 82.54B | 80.61B | -- | 78.21B | |
|
|
|||||